The goal of Dr. Annes's laboratory is to translate their laboratory discoveries to the treatment of hereditary endocrine disorders.

Dr. Angst's laboratory investigates the biological and clinical characteristics that drive resilience in humans using surgery as an interventional injury model.

Professor Andriacchi's research focuses on the biomechanics of human locomotion and its biomedical applications to artificial joints, sports injury, osteoarthritis, and neuromuscular disorders.

Dr. Katrin Andreasson's group is investigating the role that innate immune responses play in the initiation and progression of neurological diseases. Recent advances in human genetics, particularly for neurodegenerative disorders like Alzheimer’s disease, have highlighted a causal role for a disrupted immune response in disease pathogenesis. An injurious immune response may be a common denominator across many neurological disorders, both acute (brain trauma or stroke) and chronic (epilepsy, Parkinson’s disease, Alzheimer's for eg.).

The major focus of Dr. Alizadeh's research group is to attain a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to existing and novel therapies toward improving current treatment strategies.

Dr. Aiken's research focuses on developing techniques for the construction of reliable software systems.

Dr. Aijaz Ahmed's research interests include nonalcoholic fatty liver disease (NAFLD) and viral hepatitis.

The Ashley lab is focused on the application of genomics to medicine.

The Chang lab is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning.

Dr. Mackey's current research interests and projects include: virtual reality and real-time fMRI; applications of real-time fMRI Phase II; cortical restructuring in patients with chronic pain; cognitive load and perceived pain intensity; fMRI of the Human Cervical Spine; neurotoxins based therapies in chronic pain; intravenous lidocaine in neuropathic pain; outcome assessment in chronic pain; opiate induced hyperalgesia.